Thank you, New York Times, for asking ‘Who is behind these [psychedelic] studies? Where does the money come from?’
The study highlighted in this well-written article adds to a growing body of research into whether using the synthetic, psychoactive drug MDMA (street names “Ecstasy” or “Molly”) in conjunction with psychotherapy, can improve outcomes in PTSD.
1) Does the story adequately discuss the costs of the intervention? Not Satisfactory
2) Does the story adequately quantify the benefits of the treatment/test/product/procedure? Satisfactory
3) Does the story adequately explain/quantify the harms of the intervention? Satisfactory
4) Does the story seem to grasp the quality of the evidence? Not Satisfactory
5) Does the story commit disease-mongering? Satisfactory
6) Does the story use independent sources and identify conflicts of interest? Satisfactory
7) Does the story compare the new approach with existing alternatives? Satisfactory
8) Does the story establish the availability of the treatment/test/product/procedure? Satisfactory
9) Does the story establish the true novelty of the approach? Satisfactory
10) Does the story appear to rely solely or largely on a news release? Satisfactory
Total Score: 8 of 10 Satisfactory
Original Article (Health News Review):
Thank you, New York Times, for asking ‘Who is behind these studies? Where does the money come from?’
Artwork Fair Use: Big Think
